The spartnering approach, coupled with the strategic investment (should it come) will allow the company to accelerate multiple products concurrently as they want to go to market fast and cement themselves aggressively in cold x-ray tech. This menas they will spend a lot thus the focus is on products dev and revenue growth over near/mid-term profits.

https://www.asx.com.au/asxpdf/20180730/pdf/43wvvwgfzlfdpn.pdf